Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

608 ARTÍCULOS , VIENDO DEL 391 AL 405

Intracranial calcifications and dystonia associated with a novel deletion of chromosome 8p11.2 encompassing SLC20A2 and THAP1

Mu W, Tochen L, Bertsch C, Singer HS, Barañano KW.

BMJ Case Rep. 2019 May 27;12(5):e228782. doi: 10.1136/bcr-2018-228782.

A Review of Cognitive Outcomes Across Movement Disorder Patients Undergoing Deep Brain Stimulation

Cernera S, Okun MS, Gunduz A.

Front Neurol. 2019 May 7;10:419. doi: 10.3389/fneur.2019.00419. eCollection 2019.

Malignant Glioma Developed on a Patient Under Deep Brain Stimulation: Pitfalls in Management

Roldán P, Najarro R, Di Somma A, Culebras D, Hoyos JA, Compta Y, Cámara A, Muñoz E, Martí MJ, Valldeoriola F, Rumià J.

World Neurosurg. 2019 Sep;129:85-89. doi: 10.1016/j.wneu.2019.05.234. Epub 2019 May 31.

Assessment of the effects of Kinesiotaping on musical motor performance in musicians suffering from focal hand dystonia: a pilot study

Bravi R, Ioannou CI, Minciacchi D, Altenmüller E.

Clin Rehabil. 2019 Oct;33(10):1636-1648. doi: 10.1177/0269215519852408. Epub 2019 Jun 4.

ENT involvement and orobuccal movements' disorders in Pandas patients: assessment and rehabilitations tools

Cocuzza S, Marino S, Gulino A, Pustorino E, Murabito P, Maniaci A, Sabino L, Taibi R, Di Luca M, Falsaperla R, Campione G, Vecchio M, Pavone P.

Eur Rev Med Pharmacol Sci. 2019 May;23(10):4110-4117. doi: 10.26355/eurrev_201905_17912.

The Interaction of Genetic Mutations in PARK2 and FA2H Causes a Novel Phenotype in a Case of Childhood-Onset Movement Disorder

Benger M, Mankad K, Proukakis C, Mazarakis ND, Kinali M.

Front Neurol. 2019 May 29;10:555. doi: 10.3389/fneur.2019.00555. eCollection 2019.

Can neuromodulation techniques optimally exploit cerebello-thalamo-cortical circuit properties to enhance motor learning post-stroke?

Israely S, Leisman G.

Rev Neurosci. 2019 Nov 26;30(8):821-837. doi: 10.1515/revneuro-2019-0008.

Roles of the M(4) acetylcholine receptor in the basal ganglia and the treatment of movement disorders

Moehle MS, Conn PJ.

Mov Disord. 2019 Aug;34(8):1089-1099. doi: 10.1002/mds.27740. Epub 2019 Jun 18.

Aplicaciones terapéuticas por acción de los cannabinoides

Plancarte-Sánchez R, Mansilla-Olivares A, De Los Reyes-Pacheco VA, Meneses-González F.

Gac Med Mex. 2019;155(3):307-318. doi: 10.24875/GMM.18004928.

Deep Brain Stimulation Programming for Movement Disorders: Current Concepts and Evidence-Based Strategies

Koeglsperger T, Palleis C, Hell F, Mehrkens JH, Bötzel K.

Front Neurol. 2019 May 21;10:410. doi: 10.3389/fneur.2019.00410. eCollection 2019.

Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study

Wein T, Jog M, Bhogal M, Dhani S, Miller R, Ismail F, Beauchamp R, Trentin G.

Can J Neurol Sci. 2019 Nov;46(6):742-752. doi: 10.1017/cjn.2019.238.

TBC1D24-TLDc-related epilepsy exercise-induced dystonia: rescue by antioxidants in a disease model

Lüthy K, Mei D, Fischer B, De Fusco M, Swerts J, Paesmans J, Parrini E, Lubarr N, Meijer IA, Mackenzie KM, Lee WT, Cittaro D, Aridon P, Schoovaerts N, Versées W, Verstreken P, Casari G, Guerrini R.

Brain. 2019 Aug 1;142(8):2319-2335. doi: 10.1093/brain/awz175.

Use of botulinum toxin for movement disorders

Camargo CHF, Teive HAG.

Drugs Context. 2019 Jun 18;8:212586. doi: 10.7573/dic.212586. eCollection 2019.

Juvenile parkinsonism: Differential diagnosis, genetics, and treatment

Niemann N, Jankovic J.

Parkinsonism Relat Disord. 2019 Oct;67:74-89. doi: 10.1016/j.parkreldis.2019.06.025. Epub 2019 Jun 30.

Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia

Kriegel G, Stuckey MI.

Case Rep Psychiatry. 2019 Jun 4;2019:1947962. doi: 10.1155/2019/1947962. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias